Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of FYTTD1 mRNA | affects expression | 21346803
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in decreased expression of FYTTD1 mRNA | decreases expression | 16514628
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FYTTD1 mRNA | decreases expression | 20018196
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of FYTTD1 mRNA | increases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of FYTTD1 mRNA | increases expression | 16514628
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of FYTTD1 mRNA | decreases expression | 16514628
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of FYTTD1 mRNA | decreases expression | 16514628
|
C025643 |
vinclozolin |
vinclozolin affects the expression of FYTTD1 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.14 | 11473722 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.88 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.58 | 15800139 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.83 | 19015723 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
5.13 | 11514358 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.78 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.06 | 12948864 19861407 17289903 18497071 16675129 14630087 17018787 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
2.06 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.06 | 15775269 15572757 17595753 17893378 17952589 15758505 17440819 16912660 16837676 17242785 17049068 17261762 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.80 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.05 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.05 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.30 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.60 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.08 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.08 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
12.08 | 18566989 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.09 | 19486331 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.92 | 15800139 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.62 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.32 | 18551238 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.38 | 17474826 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.73 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.73 | 17308373 17451421 15920148 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
2.02 | 21346803 18551238 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.58 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
4.28 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
8.28 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
8.28 | 11473722 19148513 18566989 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.12 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.69 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
8.69 | 17473493 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.45 | 12639820 12168785 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.27 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.68 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.69 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.41 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.13 | 17088409 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.56 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
5.56 | 17577099 15787275 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
7.64 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.64 | 16467254 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.11 | 16627594 16393666 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.36 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.36 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.57 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.57 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
13.57 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.76 | 16973256 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.07 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.68 | 14659978 14716833 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.70 | 17203775 11807958 11408345 16891317 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.86 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.93 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.60 | 16497877 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.46 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.93 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.20 | 18551238 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.07 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.50 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.93 | 11399458 16427766 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.66 | 16049721 12819281 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.53 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.49 | 17823083 15579764 15758505 17893378 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.28 | 19401270 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.23 | 18220299 19015723 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.27 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.13 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.29 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.29 | 15731164 16220300 16536755 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.27 | 18629315 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.93 | 15770314 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.68 | 18551238 |
MESH:D020521 |
Stroke |
|
Raloxifene |
4.01 | 16837676 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
15.00 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
15.00 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.47 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
5.47 | 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.65 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.58 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.93 | 16343187 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |